Format

Send to

Choose Destination
J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24.

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients.

Author information

1
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.
2
Laboratory of Virology, CHU Purpan, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; Université Paul Sabatier, Toulouse, France.
3
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.
4
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; Université Paul Sabatier, Toulouse, France. Electronic address: kamar.n@chu-toulouse.fr.

KEYWORDS:

Duration; Hepatitis E virus; Ribavirin; Stools; Sustained virological response; Transplantation

PMID:
30563687
DOI:
10.1016/j.jhep.2018.09.011

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center